Results of the Annual Meeting of Stockholders of SCOLR Pharma, Inc. held on June...

* Reuters is not responsible for the content in this press release.

Fri Jun 6, 2008 10:15am EDT 

Results of the Annual Meeting of Stockholders of SCOLR Pharma, Inc. held on June 5, 2008

BELLEVUE, Wash.--(Business Wire)--
SCOLR Pharma, Inc. (AMEX: DDD) today announced the voting results
of its Annual Meeting of Stockholders, which was held on June 5, 2008
at The American Stock Exchange in New York, New York.

   At the meeting, the shareholders of the Company re-elected Randall
L-W. Caudill, D. Phil., Reza Fassihi, Ph.D., Herbert Lucas, Jr., Wayne
L. Pines, Bruce S. Morra, Jeffrey B. Reich, Michael N. Taglich,
Gregory L. Weaver and Daniel O. Wilds as directors to hold office
until the next annual meeting of stockholders. In addition,
shareholders of the Company ratified the appointment of Grant Thornton
LLP as the Company's independent registered public accounting firm for
fiscal 2008.

   No other business came before the meeting.

   About SCOLR Pharma:

   Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialty
pharmaceutical company. SCOLR Pharma's corporate objective is to
combine its formulation expertise and its patented CDT platform to
develop novel pharmaceutical, over-the-counter (OTC), and nutritional
products. Our CDT drug delivery platform is based on multiple issued
and pending patents and other intellectual property for the programmed
release or enhanced performance of active pharmaceutical ingredients
and nutritional products. For more information on SCOLR Pharma, please
call 425.373.0171 or visit http://www.scolr.com/.

Investor Relations:
Cameron Associates
Kevin McGrath, 212-245-4577
Kevin@cameronassoc.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.